Potency of an experimental DNA vaccine against Aujeszky's disease in pigs

Veterinary Microbiology

Volumn 66, Issue 1, 1999, Pages 1-13

  Gerdts, Volker ^a   Jöns, Alice ^a   Mettenleiter, Thomas C ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Aujeszky's disease; DNA immunization; Pig viruses; Vaccination

Indexed keywords

DNA VACCINE; NOBIVAC AUJESZKY; PSEUDORABIES VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PSEUDORABIES; SWINE; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; CYTOMEGALOVIRUS; ENHANCER ELEMENTS (GENETICS); GENES, ENV; HERPESVIRUS 1, SUID; HUMANS; KIDNEY; PROMOTER REGIONS (GENETICS); PSEUDORABIES; PSEUDORABIES VACCINES; SWINE; TIME FACTORS; VACCINES, DNA; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRULENCE; VIRUS SHEDDING;

ANIMALIA; HUMAN HERPESVIRUS 5; SUID HERPESVIRUS 1; SUS SCROFA;

EID: 0344197551     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(98)00300-9     Document Type: Article

References (38)

1. Andries K., Pensaert M.B., Vandeputte J. Effect of experimental infection with pseudorabies virus on pigs with maternal immunity from vaccinated sows. Am. J. Vet. Res. 39:1978;1282-1285.
2. Baskerville A. The histopathology of experimental pneumonia in pigs produced by a strain of Aujeszky's disease virus. Res. Vet. Sci. 14:1973;223-228.
3. Ben-Porat T., DeMarchi J., Lomniczi B., Kaplan A.S. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies. Virology. 154:1986;325-334.
4. Brack, A., 1996. unpublished results.
5. Cox G., Zamb T., Babiuk L.A. Bovine herpesvirus 1: immune response in mice and cattle injected with plasmid DNA. J. Virol. 67:1993;5664-5667.
6. Donelly J.J., Ulmer J.B., Shiver J.B., Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
7. Eliot M., Fargeaud D., Haridon R.L., Thoma B. Identification of pseudorabies virus glycoprotein gp 50 as a major target of neutralizing antibodies. Arch. Virol. 99:1988;45-56.
8. Fuchs W., Rziha H.-J., Lukàcs N., Braunschweiger I., Visser N., Lütticken D., Schreurs C.S., Thiel H.-J., Mettenleiter T.C. Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes. J. Gen. Virol. 71:1990;1141-1151.
9. Fynan E.F., Robinson H.L., Webster H.G. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol. 12:1993;785-789.
10. Gerdts V., Jöns A., Makoschey B., Visser N., Mettenleiter T.C. Protection of pigs against Aujeszky's disease by DNA vaccination. J. Gen. Virol. 78:1997;2138-2145.
11. Hasset D., Whitton J.L. DNA immunization. Trends Microbiol. 4:1996;307-312.
12. Hasset D.E., Zhang J., Whitton L. Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol. 71:1997;7881-7888.
13. Kaplan A.S., Vatter A. A comparison of herpes simplex and pseudorabies viruses. Virology. 13:1959;78-92.
14. Kimman T.G. Acceptability of Aujeszky's disease vaccines. Dev. Biol. Standard. 79:1992;129-136.
15. Kimman T.G., DeBruin T., Voermans J., Peeters B., Bianchi A.T. Development and antigen specificity of the lymphoproliferative response of pigs to pseudorabies virus: dichotomy between secondary B- and T-cell responses. Immunology. 86:1995;372-378.
16. Klupp, B.G., Weiland, E., unpublished results.
17. Kost T.A., Jones E., Smith K., Reed A.P., Brown A., Miller T. Biological evaluation of glycoproteins mapping to two distinct mRNAs within the BamHI fragment 7 of pseudorabies virus: expression of the coding regions by vaccinia virus. Virology. 171:1989;365-376.
18. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., Callan R., Hishaw V.S., Swain W.F. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J. Virol. 72:1998;1491-1496.
19. Marchioli C.C., Yancey R., Petrovskis E., Timmins J., Post L. Evaluation of pseudorabies virus glycoprotein gp 50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and chinese hamster ovary cells. J. Virol. 61:1987;3977-3982.
20. Mettenleiter T.C., Lukacs N., Rziha H. Pseudorabies virus avirulent strains fail to express a major glycoprotein. J. Virol. 56:1985;307-311.
21. Mettenleiter T.C. Pseudorabies (Aujeszky's disease) virus: state of the art. Acta Vet. Hung. 42:1994;153-177.
22. Mettenleiter T.C. Immunobiology of pseudorabies (Aujeszky's disease). Vet. Immunol. Immunopathol. 54:1996;221-229.
23. Monteil M., LePotier M.F., Guillotin J., Cariolet R., Houdayer C., Eloit M. Genetic immunization of seronegative one day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams. Vet. Res. 27:1996;443-452.
24. Rauh I., Mettenleiter T.C. Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J. Virol. 65:1991;5348-5356.
25. Raz E., Carson D.A., Parker S., Parr T.B., Abai A.M., Aichinger G., Gromkowski S.H., Singh M., Lew D., Yankauckas M.A., Baird S.M., Rhodes G.H. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. U.S.A. 91:1994;9519-9523.
26. Richardson J., Moraillon A., Baud S., Cuisinier A.-M., Sonigo P., Pancino G. Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J. Virol. 71:1997;9640-9649.
27. Robinson H.L., Hunt L.A., Webster R.G. Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine. 11:1993;957-960.
28. Sakaguchi M., Nakamura H., Sonoda K., Hamada F., Hirai K. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine. 14:1996;747-752.
29. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbour, New York, Cold Spring Harbour Laboratory.
30. Tang D., DeVit M., Johnston S.S. Genetic immunization is a simple method for elicting an immune response. Nature. 356:1992;152-154.
31. Ulmer J.B., Donelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., Dewitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
32. Ulmer J.B., Deck R.R., DeWitt C.M., Friedman A., Donelly J.J., Liu M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine. 12:1994;1541-1544.
33. Ulmer J., Sadoff J., Liu M.A. DNA vaccines. Curr. Opin. Immunol. 8:1996;531-536.
34. Van Oirschot J.T., Rziha H.-J., Moonen P.L.M., Pol J.M.A., Van Zaane D. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J. Gen. Virol. 67:1986;1179-1182.
35. Ward G., Rieder E., Mason P.W. Plasmid DNA encoding replicating foot-and mouth disease virus genomes induces antiviral immune response in swine. J. Virol. 71:1997;7442-7447.
36. Wathen M.W., Wathen L.M.K. Isolation, characterization and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50. J. Virol. 51:1984;57-62.
37. Wolff J.A., Malone R.W., Williams P., Chong W., Ascadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle cells in vivo. Science. 24:1990;1465-1468.
38. Zuckermann F.A., Zsak L., Mettenleiter T.C., Ben-Porat T. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes. J. Virol. 64:1990;802-812.